FDA-Inspected Site

Musculoskeletal Transplant Foundation, Inc.

8 FDA inspections are on record for Musculoskeletal Transplant Foundation, Inc. in Jessup, United States.

Clean· No action indicated

Jessup, United States · Last updated July 10, 2026

Overview

  • 8 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2022-07-14.

At a glance

Inspections

8

Form 483s

1

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Jul 2022 – 14 Jul 2022BiologicsClean
16 Jul 2019 – 19 Jul 2019BiologicsClean
7 Nov 2016 – 14 Nov 2016BiologicsClean
20 Oct 2014 – 23 Oct 2014BiologicsClean
18 Oct 2012Not recorded483View 483 →
4 Nov 2010Not recordedClean
1 Oct 2008Not recordedClean
13 May 2004Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

18 Oct 2012
21 CFR 1271.160(b)(5)

Monitoring systems

Cited by Juanita P Versace, Ann-Marie Karnick, Kimberly A Dux, Eufemia G Gonzalez

18 Oct 2012
21 CFR 1271.180(a)

Procedures to meet core CTGP

Cited by Juanita P Versace, Ann-Marie Karnick, Kimberly A Dux, Eufemia G Gonzalez

18 Oct 2012
21 CFR 1271.195(c)

Monitoring--cross contamination, exposure to CD

Cited by Juanita P Versace, Ann-Marie Karnick, Kimberly A Dux, Eufemia G Gonzalez

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.160(b)(5)Cited across public-safe Form 483 observations1x
21 CFR 1271.180(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.195(c)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Musculoskeletal Transplant Foundation, Inc.'s 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat